Kaiser Health News
Opinion writers weigh in on these health issues and others.
Read recent commentaries about drug-cost issues.
News outlets report on stories related to pharmaceutical pricing.
Media outlets report on news from California, Washington, Wyoming, Kansas, Michigan, Pennsylvania, Wisconsin, Arizona, Florida, Ohio, Connecticut, New York, Georgia, Louisiana and Texas.
News from state legislatures comes out of Connecticut, Georgia and Massachusetts.
According to new documents, the University of Illinois at Chicago Institutional Review Board, the committee responsible for protecting research subjects, improperly fast-tracked approval of Dr. Mani Pavuluri’s clinical trial, didn’t catch serious omissions from the consent forms parents had to sign and allowed children to enroll in the study even though they weren’t eligible. Still, UIC officials have continued to blame only Pavuluri, and have downplayed the institution's role in the research.
The measure, if it becomes law, would require weekly work hours for Medicaid recipients but carves out people with physical and mental conditions. It's one of several measures moving through red states that would impose restrictions on the program. Medicaid news comes out of New Hampshire and Pennsylvania, as well.
Britain’s National Portrait Gallery has announced it won’t proceed with a $1.3 million pledge from a charitable organization overseen by some members of the Sackler family, which founded Purdue Pharma. A recent court case has been shedding light on just how large a role the family played in the aggressive marketing of the painkillers.
The genetic disease, fibrodysplasia ossificans, in which the body’s machinery for healing goes awry, growing immovable bone where it doesn’t belong, had been languishing as nothing more than a medical curiosity. But a community of patient advocates rallied, and now there are three medicines in human trials, the most advanced of which could win Food and Drug Administration approval next year. In other public health news: weight lifting, primate emotions, the "bliss point" in food, and psychic mediums.
Experts say that this should temper some of the enthusiasm that's been growing about the healthfulness of marijuana. They also say it provides reasoning behind putting some restrictions on legalized use of the drugs--such as making sure high-potency versions are harder to get.